Deepa M. Gopal

1.4k total citations
49 papers, 983 citations indexed

About

Deepa M. Gopal is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Deepa M. Gopal has authored 49 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 15 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Deepa M. Gopal's work include Cardiovascular Function and Risk Factors (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers) and Pulmonary Hypertension Research and Treatments (8 papers). Deepa M. Gopal is often cited by papers focused on Cardiovascular Function and Risk Factors (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers) and Pulmonary Hypertension Research and Treatments (8 papers). Deepa M. Gopal collaborates with scholars based in United States, Taiwan and Australia. Deepa M. Gopal's co-authors include Wilson S. Colucci, Nir Ayalon, Jill Downing, Chang‐seng Liang, Omar K. Siddiqi, Frederick L. Ruberg, Deborah A. Siwik, Flora Sam, W.H. Wilson Tang and Vasiliki V. Georgiopoulou and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Genome Research.

In The Last Decade

Deepa M. Gopal

41 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepa M. Gopal United States 17 477 287 138 115 112 49 983
Koichiro Fujisue Japan 19 582 1.2× 234 0.8× 129 0.9× 86 0.7× 110 1.0× 60 1.1k
Deddo Mörtl Austria 18 688 1.4× 221 0.8× 141 1.0× 125 1.1× 77 0.7× 28 1.2k
Wilson Tong United States 11 586 1.2× 161 0.6× 187 1.4× 155 1.3× 85 0.8× 15 1.1k
Tomoo Furumoto Japan 17 442 0.9× 170 0.6× 104 0.8× 85 0.7× 74 0.7× 34 888
Alessandro Fucili Italy 16 441 0.9× 365 1.3× 94 0.7× 51 0.4× 55 0.5× 29 1.1k
Samir Kapadia United States 8 855 1.8× 374 1.3× 83 0.6× 124 1.1× 38 0.3× 35 1.3k
Eiichiro Yamamoto Japan 14 337 0.7× 290 1.0× 177 1.3× 61 0.5× 38 0.3× 34 946
Andrea Baessler Germany 20 345 0.7× 330 1.1× 219 1.6× 136 1.2× 66 0.6× 53 1.1k
Niels Engberding United States 7 465 1.0× 324 1.1× 171 1.2× 53 0.5× 85 0.8× 8 892

Countries citing papers authored by Deepa M. Gopal

Since Specialization
Citations

This map shows the geographic impact of Deepa M. Gopal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepa M. Gopal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepa M. Gopal more than expected).

Fields of papers citing papers by Deepa M. Gopal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepa M. Gopal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepa M. Gopal. The network helps show where Deepa M. Gopal may publish in the future.

Co-authorship network of co-authors of Deepa M. Gopal

This figure shows the co-authorship network connecting the top 25 collaborators of Deepa M. Gopal. A scholar is included among the top collaborators of Deepa M. Gopal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepa M. Gopal. Deepa M. Gopal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodriguez, Jennifer, Manuel A. Morales, Long Ngo, et al.. (2025). Exercise cardiovascular magnetic resonance myocardial dynamic index: A non-invasive imaging marker associated with cardiac dyspnea. Journal of Cardiovascular Magnetic Resonance. 27(2). 101981–101981.
2.
Lui, Justin K., Marcin A. Trojanowski, Renda Soylemez Wiener, et al.. (2023). Role of Left Ventricular Dysfunction in Systemic Sclerosis-Related Pulmonary Hypertension. CHEST Journal. 165(6). 1505–1517. 3 indexed citations
3.
Farb, Melissa G., Nir Ayalon, Charlotte Andersson, et al.. (2023). Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart Study. Journal of the American Heart Association. 12(12). e028022–e028022. 19 indexed citations
4.
Lui, Justin K., Robert Smyth, Deepa M. Gopal, et al.. (2023). A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension. Lung. 201(6). 565–569.
5.
Shah, Ravi V., Shih‐Jen Hwang, Venkatesh L. Murthy, et al.. (2023). Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study. Journal of the American Heart Association. 12(21). e029980–e029980. 2 indexed citations
6.
Gustine, Joshua, Andrew Staron, Lisa Mendelson, et al.. (2023). Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis. Blood Advances. 7(20). 6080–6091. 9 indexed citations
7.
Nakamori, Shiro, Selçuk Küçükseymen, Jennifer Rodriguez, et al.. (2023). Obesity-Related Differences in Pathomechanism and Outcomes in Patients With HFpEF. JACC Advances. 2(10). 100730–100730. 5 indexed citations
8.
Lui, Justin K., Marcin A. Trojanowski, Andreea M. Bujor, et al.. (2023). Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovascular Drugs and Therapy. 38(3). 651–656. 1 indexed citations
9.
Gower, Adam C., Yuriy O. Alekseyev, Seung Hyun Choi, et al.. (2022). Systematic dissection, preservation, and multiomics in whole human and bovine hearts. Cardiovascular Pathology. 63. 107495–107495.
10.
Mendelson, Lisa, Varsha Muralidhar, John L. Berk, et al.. (2022). Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging. The American Journal of Cardiology. 181. 105–112. 6 indexed citations
11.
Mendelson, Lisa, John L. Berk, Vaishali Sanchorawala, et al.. (2021). TREATING TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A COMPARISON OF DIFLUNISAL AND TAFAMIDIS. Journal of the American College of Cardiology. 77(18). 3296–3296. 5 indexed citations
12.
Marcus, Rachel, et al.. (2020). Testing for Chagas disease in an at-risk population. Journal of Cardiac Failure. 27(1). 109–111. 5 indexed citations
13.
Berk, John L., Lawreen H. Connors, Gheorghe Doros, et al.. (2019). Abstract 13123: Diflunisal is Associated With Improved Mortality in Patients With Wild-Type ATTR Cardiac Amyloidosis: The BU Amyloidosis Center Experience. Circulation. 2 indexed citations
14.
Mussinelli, Roberta, Deepa M. Gopal, John L. Berk, et al.. (2019). Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis. Journal of Cardiac Failure. 26(9). 753–759. 77 indexed citations
15.
Gopal, Deepa M., et al.. (2019). Epidemiology of Atrial Fibrillation and Heart Failure. Cardiology Clinics. 37(2). 119–129. 42 indexed citations
16.
Gopal, Deepa M., Frederick L. Ruberg, & Omar K. Siddiqi. (2019). Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. Current Heart Failure Reports. 16(5). 180–188. 10 indexed citations
17.
Luk, Adriana, John D. Groarke, Akshay S. Desai, et al.. (2018). First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization. American Heart Journal. 203. 95–100. 38 indexed citations
18.
Gopal, Deepa M. & Flora Sam. (2013). New and Emerging Biomarkers in Left Ventricular Systolic Dysfunction—Insight into Dilated Cardiomyopathy. Journal of Cardiovascular Translational Research. 6(4). 516–527. 31 indexed citations
19.
Gopal, Deepa M., Andreas P. Kalogeropoulos, Vasiliki V. Georgiopoulou, et al.. (2012). Cigarette smoking exposure and heart failure risk in older adults: The Health, Aging, and Body Composition Study. American Heart Journal. 164(2). 236–242. 72 indexed citations
20.
Gopal, Deepa M., Andreas P. Kalogeropoulos, Vasiliki V. Georgiopoulou, et al.. (2010). Serum albumin concentration and heart failure risk. American Heart Journal. 160(2). 279–285. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichiro Fujisue Breakdown of academic impact, for papers by Deddo Mörtl Breakdown of academic impact, for papers by Wilson Tong Breakdown of academic impact, for papers by Tomoo Furumoto Breakdown of academic impact, for papers by Alessandro Fucili Breakdown of academic impact, for papers by Samir Kapadia Breakdown of academic impact, for papers by Eiichiro Yamamoto Breakdown of academic impact, for papers by Andrea Baessler Breakdown of academic impact, for papers by Niels Engberding
Rankless by CCL
2026